RxDoctor Payments Data

Robert Bookman, MD

Hospitalist · Lagrange, GANPI 1164953121

Payments from drug & device makers

$448in general payments, 2019–2025

Across 24 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$147
  • Pfizer$126
  • Urgo Medical North America, LLC$42
  • Organogenesis Inc.$26
  • Lifenet Health$26
  • Cashflow Solutions, LLC$20
  • plus $61 from 4 others

What the payments were for

  • Food & beverage$448100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew8$147
Pfizer7$126
Urgo Medical North America, LLC2$42
Organogenesis Inc.1$26
Lifenet Health1$26
Cashflow Solutions, LLC1$20
AstraZeneca1$20
Solventum Corporation1$17
Hydrofera LLC1$13
Biowound Solutions, Inc.1$11

How this compares

$448 in reported general payments places this provider in the 70th percentile of 812 hospitalist providers in Georgia.

See all hospitalist providers in Georgia

Medicare billing

Part B allowed, 2024
$88,342
Medicare patients
238
Services billed
787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.14$9,751
Doxycycline Hyclate55$440
Potassium Chloride54$326
Pantoprazole Sodium44$271
Atorvastatin Calcium67$220
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$139
Ciprofloxacin Hcl18$111
Albuterol Sulfate HfaAlbuterol Sulfate12$97
Prednisone18$56
Levofloxacin13$39
Metoprolol Tartrate11$21
Amlodipine Besylate13$18

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$147$9,75114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 812 hospitalist providers in Georgia.

Other hospitalist in Lagrange

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →